These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5460748)

  • 1. The synthesis of (1-deamino,4-L-leucine)-oxytocin and (1-deamino,4-L-isoleucine)-oxytocin and some of their pharmacological properties.
    Takashima H; Hruby VJ; Du Vigneaud V
    J Am Chem Soc; 1970 Feb; 92(3):677-80. PubMed ID: 5460748
    [No Abstract]   [Full Text] [Related]  

  • 2. The synthesis and some of the pharmacological properties of [4-L-isoleucine]-oxytocin and [4-L-leucine]-oxytocin.
    Hruby VJ; Flouret G; du Vigneaud V
    J Biol Chem; 1969 Jul; 244(14):3890-4. PubMed ID: 5817165
    [No Abstract]   [Full Text] [Related]  

  • 3. The synthesis and some pharmacological activities of[4-L-norvaline]-oxytocin and [4-L-norleucine]-oxytocin and their deamino analogs.
    Flouret G; Du Vigneaud V
    J Med Chem; 1969 Nov; 12(6):1035-8. PubMed ID: 5389145
    [No Abstract]   [Full Text] [Related]  

  • 4. Crystalline deamino-dicarba-oxytocin. Preparation and some pharmacological properties.
    Yamanaka T; Hase S; Sakakibara S; Schwartz IL; Dubois BM; Walter R
    Mol Pharmacol; 1970 Sep; 6(5):474-80. PubMed ID: 5466703
    [No Abstract]   [Full Text] [Related]  

  • 5. [Synthesis and some pharmacological activities of [2-L-valine]-oxytocin and [2-L-leucine]-oxytocin.
    Hruby VJ; Du Vigneaud V
    J Med Chem; 1969 Sep; 12(5):731-3. PubMed ID: 5818088
    [No Abstract]   [Full Text] [Related]  

  • 6. Syntheses and pharmacological properties of selenium isologs of oxytocin and deamino-oxytocin.
    Walter R; Chan WY
    J Am Chem Soc; 1967 Jul; 89(15):3892-8. PubMed ID: 6068786
    [No Abstract]   [Full Text] [Related]  

  • 7. Solid-phase synthesis of (2-isoleucine, 4-leucine) oxytocin and (2-phenylalanine, 4-leucine) oxytocin and some their pharmacological properties.
    Hruby VJ; Muscio F; Gronginsky CM; Gitu PM; Saba D; Chan WY
    J Med Chem; 1973 Jun; 16(6):624-9. PubMed ID: 4733119
    [No Abstract]   [Full Text] [Related]  

  • 8. Solid-phase synthesis of (4-threonine)-oxytocin. A more potent and specific oxytocic agent than oxytocin.
    Manning M; Coy E; Sawyer WH
    Biochemistry; 1970 Sep; 9(20):3925-30. PubMed ID: 5533681
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of an amide group in place of the disulfide bridge in deamino-oxytocin.
    Hase S; Sakakibara S; Wahrenburg M; Walter R
    J Med Chem; 1972 Oct; 15(10):1017-9. PubMed ID: 4672192
    [No Abstract]   [Full Text] [Related]  

  • 10. 4-Threonine analogues of neurohypophysial hormones withh selectively enhanced oxytocin-like activities.
    Sawyer WH; Manning M
    J Endocrinol; 1971 Jan; 49(1):151-65. PubMed ID: 5104449
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z; Lammek B; Gazis D; Schwartz IL
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and some pharmacological properties of [4-homoserine]oxytocin.
    Turan A; Manning M; Haldar J; Sawyer WH
    J Med Chem; 1977 Sep; 20(9):1169-72. PubMed ID: 926116
    [No Abstract]   [Full Text] [Related]  

  • 13. 2-Isoleucine-oxytocin and deamino-2-isoleucine-oxytocin: their synthesis and some of their pharmacologic activities.
    Branda LA; Hruby VJ; Du Vigneaud V
    Mol Pharmacol; 1967 May; 3(3):248-53. PubMed ID: 6068341
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and some pharmacological properties of 8-L-methionine-oxytocin.
    Bodanszky M; Chandramouli N; Martinez J; Walter R
    J Med Chem; 1979 Mar; 22(3):270-3. PubMed ID: 423209
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
    Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and some pharmacological properties of (1-deamino,9-thioglycine)oxytocin.
    Jones WC; Nestor JJ; Du Vigneaud V
    J Am Chem Soc; 1973 Aug; 95(17):5677-9. PubMed ID: 4733810
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of cyclic analogues of deamino-oxytocin not containing a disulphide bond (carba analogues).
    Barth T; Krejcí I; Kupková B; Jost K
    Eur J Pharmacol; 1973 Nov; 24(2):183-8. PubMed ID: 4797285
    [No Abstract]   [Full Text] [Related]  

  • 18. Deuterated oxytocins: the synthesis and biological properties of a crystalline analog of deamino-oxytocin deuterated in the 5-asparagine position.
    Blomquist AT; Rich DH; Carlson BA; Allen GA; Hruby VJ; Takashima H; Nangeroni LL; Glose P; Du Vigneaud V
    Proc Natl Acad Sci U S A; 1969 Sep; 64(1):263-6. PubMed ID: 5263009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
    Roy J; Roy U; Gazis DC; Schwartz IL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of decreasing the size of the ring present in deamino-oxytocin by one methylene group on its biological properties. The synthesis of 1-mercaptoacetic acid-oxytocin.
    Jarvis D; Du Vigneaud V
    J Biol Chem; 1967 Apr; 242(8):1768-71. PubMed ID: 6067284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.